Erratum: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva (Nature Genetics (2006) 38, (525-527))

Erratum: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva (Nature Genetics (2006) 38, (525-527))

Bibliographic Details
Main Authors:	Shore, E, Xu, M, Feldman, G, Fenstermacher, D, Cho, T, Choi, I, Connor, J, Delai, P, Glaser, D, LeMerrer, M, Morhart, R, Rogers, J, Smith, R, Triffitt, J, Urtizberea, J, Zasloff, M, Brown, M, Kaplan, F
Format:	Journal article
Language:	English
Published:	2007

Similar Items

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
by: Shore, E, et al.
Published: (2006)

Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et al.
by: Kaplan, F, et al.
Published: (2008)

Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva.
by: Virdi, A, et al.
Published: (1999)

Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.
by: Petrie, K, et al.
Published: (2009)

Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.
by: Petrie, K, et al.
Published: (2009)

Fibrodysplasia ossificans progressiva: Lumps, bumps and biologics
by: Atukorala, I, et al.
Published: (2007)

Investigation of kinase activation in fibrodysplasia ossificans progressiva
by: Sanvitale, CE
Published: (2014)

Challenges and opportunities for drug repositioning in Fibrodysplasia ossificans progressiva
by: Ventura, F, et al.
Published: (2021)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
by: Williams, E, et al.
Published: (2021)

Development of BMP type I receptor kinase inhibitors for the treatment of fibrodysplasia ossificans progressiva and the study of the BMP signaling pathway
by: Mohedas, Agustin Humberto
Published: (2014)

Identification of a novel mutation in activin receptor type 1 (ACVR1) in a fibrodysplasia ossificans progressiva (FOP) patient
by: Petrie, K, et al.
Published: (2007)

Fibrodysplasia ossificans progressiva : current concepts from bench to bedside
by: Kaliya-Perumal, Arun-Kumar, et al.
Published: (2021)

ABNORMAL BONE FORMATION IN ANKYLOSING SPONDYLITIS: WHAT CAN WE LEARN FROM ACVR1 AND FIBRODYSPLASIA OSSIFICANS PROGRESSIVA?
by: Cain, P, et al.
Published: (2010)

Lymphoblastoid cells in fibrodysplasia ossificans progressiva - Do they play a role?
by: Cohen, T, et al.
Published: (2004)

An atypical mutation in the activin a receptor, type 1 gene (ACVR1) in a severely affected Fibrodysplasia Ossificans Progressiva patient
by: Petrie, K, et al.
Published: (2007)

A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date
by: Gregson, C, et al.
Published: (2011)

A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.
by: Gregson, C, et al.
Published: (2011)

A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.
by: Gregson, C, et al.
Published: (2011)

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.
by: Chaikuad, A, et al.
Published: (2012)

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva
by: Chaikuad, A, et al.
Published: (2012)

Living with fibrodysplasia ossificans progressiva: radiological images of a patient with extensive heterotopic ossification
by: Mohammed Mostafa Kotb, et al.
Published: (2023)

Development of macrocycle kinase inhibitors for ALK2 using Fibrodysplasia ossificans progressiva‐derived endothelial cells
by: Sánchez‐Duffhues, G, et al.
Published: (2019)

Congenital hallux valgus occurs in Fibrodysplasia Ossificans Progressiva and BMPR1B- associated dysplasia: an important distinction
by: Shirodkar, D, et al.
Published: (2024)

Treatment of myositis ossificans progressiva with a diphosphonate.
by: Russell, R, et al.
Published: (1972)

ACUTE PHASE REACTANTS IN MYOSITIS-OSSIFICANS PROGRESSIVA AND IN ACQUIRED ECTOPIC OSSIFICATION
by: Forster, S, et al.
Published: (1988)

Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
by: Mohedas, A, et al.
Published: (2014)

Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
by: Smith, R, et al.
Published: (1976)

Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP)
by: Smilde, BJ, et al.
Published: (2022)

CCS527 – Internet Of Things
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (2023)

ACVR1 mutations in DIPG: lessons learned from FOP.
by: Taylor, K, et al.
Published: (2014)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
by: Taylor, K, et al.
Published: (2014)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
by: Taylor, K, et al.
Published: (2014)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.
by: Taylor, K, et al.
Published: (2014)

Efficient coupling of 527 nm laser beam power to a long scalelength plasma
by: Moody, J, et al.
Published: (2006)

HRT525 - Perpectives In English Language
by: PPIK, Pusat Pengajian Ilmu Kemanusiaan
Published: (2018)

PLG 525 - Dinamik Organisasi Pendidikan
by: PPIP, Pusat Pengajian Ilmu Pendidikan
Published: (1995)

525 ways to be a better manager /
by: 254272 Coleman, Ron, et al.
Published: (1990)

BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction.
by: Sun, J, et al.
Published: (2006)

Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas
by: Fortin, J, et al.
Published: (2020)

Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache: Interventional procedures guidance [IPG527]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2015)